[ET Net News Agency, 30 October 2023] EVEREST MED-B (01952) rose 9.6% to HK$28.45.
It hits an intra-day high of HK$28.55, and an intra-day low of HK$26.2. The total shares
traded was 4.59 million, with a value of HK$125.61m. The active buy/sell ratio is 65:35,
with net buying turnover of HK$36.36m. MORGAN STANLEY HK SEC accounts for greatest net
responsive buying turnover of HK$2.39m, with volume weighted average price of HK$27.549.
CITIGROUP GLOBAL accounts for greatest net responsive selling turnover of HK$8.8m, with
volume weighted average price of HK$27.133. The stock has risen a combined 28.7% over the
past 2 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 28.450 % Chg +9.63%
High 28.550 Low 26.200
Shares Tr 4.59m Turnover 125.61m
10-D SMA 25.025 %H.V 80.645
20-D SMA 25.018 VWAP 27.354
50-D SMA 21.364 RSI14 66.504
----------------------------------
Status: Active buy/sell ratio is 65:35, with net buying turnover of HK$36.36m, rising a
combined 28.7% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 28.45 +9.63
GENSCRIPT BIO (01548) 21.85 +4.55
INNOVENT BIO (01801) 47.45 +5.44
JXR (01951) 3.96 +5.88
WUXI BIO (02269) 50.70 +6.18
WUXI APPTEC (02359) 101.40 +3.26
BEIGENE (06160) 116.80 +11.13
ASCENTAGE-B (06855) 25.55 +7.81
AKESO (09926) 43.65 +5.69
ALPHAMAB-B (09966) 11.96 +4.00
---------------------------------------------
(ed)